Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Cerilliant
Colorcon
Harvard Business School
Chubb
Boehringer Ingelheim
Express Scripts
US Department of Justice

Generated: August 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021794

« Back to Dashboard

NDA 021794 describes ACZONE, which is a drug marketed by Allergan and Allergan Inc and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ACZONE profile page.

The generic ingredient in ACZONE is dapsone. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 021794
Tradename:ACZONE
Applicant:Allergan
Ingredient:dapsone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021794
Ingredient-typeSulfones
Medical Subject Heading (MeSH) Categories for 021794
Suppliers and Packaging for NDA: 021794
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACZONE dapsone GEL;TOPICAL 021794 NDA Allergan, Inc. 0023-3670 N 0023-3670-03
ACZONE dapsone GEL;TOPICAL 021794 NDA Allergan, Inc. 0023-3670 N 0023-3670-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength5%
Approval Date:Jul 7, 2005TE:ABRLD:Yes

Expired US Patents for NDA 021794

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ACZONE dapsone GEL;TOPICAL 021794-001 Jul 7, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ACZONE dapsone GEL;TOPICAL 021794-001 Jul 7, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ACZONE dapsone GEL;TOPICAL 021794-001 Jul 7, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
UBS
Teva
Colorcon
Julphar
Daiichi Sankyo
AstraZeneca
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.